School of Medicine
Showing 1-40 of 40 Results
-
Afik Faerman
Postdoctoral Scholar, Psychiatry
BioAfik Faerman, Ph.D., is a clinical neuropsychology postdoctoral scholar and an NIMH T32 fellow at the Stanford Brain Stimulation Lab (PI: Nolan Williams) and the Center for Stress and Health (PI: David Spiegel). He completed his clinical training at the University of California, San Francisco (UCSF) and Baylor College of Medicine and earned his Ph.D. in clinical psychology with an emphasis in neuropsychology from Palo Alto University. His research centers on cognitive functioning and its intersection with behavioral health. His work has been acknowledged and supported by the American Psychological Association (APA) Division 40 (Clinical Neuropsychology) and Division 19 (Military Psychology), the Sleep Research Society (SRS), the Society for Clinical and Experimental Hypnosis (SCEH), and more. He is serving as president of the APA Division 30 (Psychological Hypnosis), the past chair of the Student Committee at the Association for the Scientific Study of Consciousness (ASSC), and a past committee member of the SRS Trainee Education and Advisory Committee (TEAC).
-
Gracia Fahed, MD
Postdoctoral Scholar, Cardiovascular Institute
BioDr. Fahed earned her medical degree from the American University of Beirut (AUB) in Lebanon. She graduated at the top of her class and was recognized for her outstanding academic achievements and compassionate patient care. Over the course of her medical studies, Dr. Fahed concentrated her research on understanding the pathophysiology behind endothelial dysfunction, hypertension and the metabolic syndrome. As a postdoctoral scholar in the Stanford Cardiovascular Institute, she now focuses on left ventricular diastolic dysfunction and early diagnosis of genetic cardiomyopathy, with a specific focus on transthyretin cardiac amyloidosis, a serious yet often overlooked cause of heart failure. Dr. Fahed aims to improve risk-stratification to enhance diagnostic care and improve cardiovascular outcomes.
-
Emily Ferguson, PhD
Postdoctoral Scholar, Psychiatry
BioEmily Ferguson, Ph.D., is a postdoctoral academic researcher and clinician within Stanford University’s Autism and Developmental Disorders Research Program (https://med.stanford.edu/autism.html) within the Department of Psychiatry and Behavioral Sciences. She earned her doctoral degree in Clinical Psychology from the University of California Santa Barbara and completed her clinical internship at the University of California Los Angeles. Dr. Ferguson's research focuses on advancing understanding of mechanisms of challenging behaviors in autistic youth and adults to inform treatment development. Her work takes a comprehensive perspective, integrating methods from implementation science to improve the accessibility and quality of clinical care for underserved autistic populations, especially those with higher support needs (or "profound autism"). She is also interested in developing methods to improve self-regulation in individuals with profound autism to effectively manage self-injurious behaviors and aggression. Dr. Ferguson is currently supporting research in the Preschool Autism Lab (https://med.stanford.edu/autismcenter/pre-school-autism-lab-program.html), and exploring profiles of challenging behaviors with the Program for Psychometrics and Measurement-Based Care (https://med.stanford.edu/sppmc.html) in a diverse range of autistic and non-autistic youth to inform treatment approaches.
-
Sonia Ferkel
Postdoctoral Scholar, Gastroenterology
Bio08/2023 - Present: Postdoctoral Scholar - Precision Medicine, Spatial-Omic Technologies - Stanford University
2023: Preclinical Research Trainee - Translational Molecular Sciences - Max Planck-Institute for Multidisciplinary Sciences Göttingen, Germany
2021 - 2022: Clinical Intern - Focus on Oncology and Gastroenterology - University Medical Center Göttingen, Germany -
Dorien Feyaerts
Instructor, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsBiomedical scientist and immunologist with a strong background in fetal-maternal immunology that aims to conduct impactful translational research in women’s health to improve the health of mothers and their children.
-
Priya Fielding-Singh
Postdoctoral Scholar, SCRDP/ Heart Disease Prevention
BioI am a Sociologist and Postdoctoral Fellow in Cardiovascular Disease Prevention at the Stanford Prevention Research Center. My research examines health, gender, and social inequality.
My primary research agenda investigates health disparities across class, race, and gender in the United States. I draw on both qualitative and quantitative methods to understand how neighborhoods, schools, and families shape our health behaviors and outcomes. My work has been published in journals such as Social Science & Medicine, Obesity, Sociological Science, and the Journal of Adolescent Health.
I hold a Ph.D. in Sociology from Stanford University, a M.A. in Anthropology from the University of Bremen, and a B.S. in Education and Social Policy from Northwestern University. -
Adina S. Fischer, MD, PhD
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioDr. Fischer’s research focuses on characterizing risk and resilience factors in depression. She has been awarded an NIH Career Development Award (K23) and Klingenstein Foundation Fellowship in Adolescent Depression to build her program of clinical and translational research at Stanford. Dr. Fischer's program of clinical care focused on the delivery and teaching of evidence-based clinical interventions that enhance resilience, with a focus on addressing the unique stressors encountered in academia and academic medicine that may contribute to risk and resilience in mood and anxiety disorders.
Dr. Fischer’s translational program of research focuses on:
(1) Improving our understanding of protective biomarkers of resilience to depression
(2) Characterizing the effects of cannabis on neurobiological function and depressive symptoms
(3) Developing neurobiologically-guided interventions for depressive disorders, particularly those that co-occur with cannabis and other substance use
Dr. Fischer earned her BSc at the Massachusetts Institute of Technology in Brain and Cognitive Sciences, where she conducted research in the Early Childhood Cognition Laboratory. She then completed the MD/PhD Program at Dartmouth, where she obtained her PhD in in Neuroscience. Dr. Fischer’s doctoral research focused on characterizing the acute effects of cannabis in patients with schizophrenia and co-occurring cannabis use disorder. She then completed the Stanford Psychiatry Residency Training Program as a member of the Research Track, and an NIH funded T-32 postdoctoral research fellowship within the Department of Psychiatry and Behavioral Sciences. -
Jelle Folkerts
Postdoctoral Scholar, Pathology
BioDr. Folkerts received his master's degree in Drug Innovation from Utrecht University in the Netherlands, during which he spent a year at the Galli lab at Stanford on a Fulbright Scholarship. During this time, Dr. Folkerts played a key role in developing a technology platform employing functional genomics and high-resolution single-cell confocal imaging, enabling the rapid identification of degranulation regulators in primary human mast cells. Following his time at Stanford, Dr. Folkerts studied the regulatory mechanisms of human mast cell activation under the guidance of Rudi Hendriks and Marcus Maurer, earning his Ph.D. in 2022. He then returned to Stanford as a postdoctoral fellow in the Galli lab, where his current research focuses on the identification of human mast cell degranulation regulators using a whole-genome CRISPR knockout library screen, and the validation of these findings using the recently developed technology platform. It is his long-standing goal to contribute to the design and development of specific and effective therapeutic interventions for mast cell-mediated diseases.
-
Jenna Forsyth
Academic Program Professional, Medicine - Med/Infectious Diseases
BioJenna is a research scientist with the School of Medicine and affiliated with the King Center for Global Development, the Woods Institute for the Environment and the Doerr School of Sustainability. She completed her PhD with the Emmett Interdisciplinary Program in Environment and Resources and obtained her Master's in Civil and Environmental Engineering from the University of Washington. Her research brings together principles of environmental science, epidemiology, and behavior change. She develops and evaluates interventions to minimize exposures to contaminants and disease vectors in low-income countries. Her most recent research has focused on lead exposure in South Asia.
-
Brandy M. Fox
Postdoctoral Scholar, Biomedical Ethics
BioBrandy M. Fox, Ph.D., is a Research Fellow at the Stanford Center for Biomedical Ethics with support from a National Human Genome Research Institute’s Ethical Legal and Social Implications (ELSI) Program training grant. She received her Ph.D. in Health Care Ethics with a concentration in Empirical Research from The Albert Gnaegi Center for Health Care Ethics at Saint Louis University under the supervision of Harold Braswell. She also holds a BA in Politics from The Catholic University of America and an MS in Health Care Ethics from Creighton University. Brandy served as an officer in the US Army and has worked for the Department of Veterans Affairs and Creighton University School of Pharmacy and Health Professions. Brandy is interested in the impact of genetic research on mental health diagnoses and treatment, including how mental illness is defined and conceptualized.
-
Marina Francis
Postdoctoral Scholar, Radiation Therapy
BioDr. Francis is a Postdoctoral Scholar in Dr. Everett Moding’s lab at the Department of Radiation Oncology. She uses genomic analysis of patient samples and preclinical models to identify new targets that sensitize sarcoma to treatments like radiation and immunotherapy. Before joining Stanford University, she completed her PhD in Biomedical Sciences at the American University of Beirut, where she worked in Dr. Youssef Zeidan’s lab investigating the role of the sphingolipid-modifying enzyme SMPDL3b in radiation nephropathy. Her research interests revolve around improving cancer treatment outcomes and patients’ quality of life by optimizing radiation therapy, combined treatment strategies, personalized precision oncology, and mitigating collateral treatment-associated toxicities.
-
J. Matthew Franklin
Postdoctoral Scholar, Genetics
Current Research and Scholarly InterestsMatt Franklin is investigating the regulation of repetitive DNA arrays in the human genome by transcription factors. This research utilizes super-resolution microscopy, proximity labeling, gene editing, and long-read genomics technologies.
-
Raquel Fueyo
Postdoctoral Scholar, Chemical and Systems Biology
Current Research and Scholarly InterestsI am a stem cell biologist interested in gene regulatory mechanisms. My long-term goal is to answer fundamental questions on the complex interactions between transposable elements and the biology of cells in embryogenesis and cancer.